Navigation Links
Researchers from 5 countries to test hygiene hypothesis with EU funding
Date:5/28/2008

High living standards and the life style connected to them seem to promote the development of autoimmune diseases and allergic symptoms. This has lead to the assumption that the immune system begins to overreact to the organisms own structures or to exogenous non-infectious proteins, i.e. allergens, when it does not have to work hard enough to protect the individual from infections.

The European Union with its Seventh Framework Program has allocated 6 million euros to the University of Helsinki coordinated DIABIMMUNE research project for the years 2008-2013 to establish whether the decrease in the infection load is connected to type 1 diabetes and the emergence of allergies.

The project comprises 12 partners from five countries. The study will include 7 000 children from Finland, Estonia and Russian Karelia in northwestern Russia. In each country the study will follow more than 300 children from birth to their 3rd birthday. In addition, the research will focus on 2 000 children from their third to fifth birthdays.

Earlier we have studied autoimmune phenomena and allergic responses in Finnish and Russian Karelian school children. Now we are to study infants and toddlers in order to yield new information on the maturation of the immune system and the interaction between the immune system and the environment, says Professor Mikael Knip from the University of Helsinki.

Based on earlier studies it is known that the incidence of type 1 diabetes is six times higher and the prevalence of celiac disease five times higher among Finnish children than among Russian Karelian children. The HLA gene variants that predispose people to autoimmune diseases are however approximately equally common in both populations. The studies have also revealed that Russian Karelian school children have helicobacter antibodies as signs of earlier infections 15 times more often, Toxoplasma antibodies five times more often, and hepatitis A antibodies 12 time
'/>"/>

Contact: Mikael Knip
mikael.knip@helsinki.fi
358-408-447-671
University of Helsinki
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Stanford researchers find culprit in aging muscles that heal poorly
2. UCLA researchers identify markers that may predict diabetes in still-healthy people
3. Mayo Clinic researchers discover new diagnostic test for detecting infection in prosthetic joints
4. Bipolar disorder relapses halved by Melbourne researchers
5. Cell that triggers symptoms in allergy attacks can also limit damage, Stanford researchers find
6. High and mighty: first common height gene identified by researchers behind obesity gene finding
7. Researchers estimate about 9 percent of US children age 8 to 15 meet criteria for having ADHD
8. Majority of 2.4 Million U.S. Children With ADHD Not Diagnosed or Consistently Treated, According to New Gold Standard Study by Cincinnati Childrens Researchers
9. Researchers develop long-lasting growth hormone
10. Jefferson immunology researchers halt lethal rabies infection in brain
11. Purdue researchers develop technology to detect cancer by scanning surface veins
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... VA (PRWEB) , ... July 02, 2015 , ... sweetFrog ... Texas. The opening is now the 19th sweetFrog store located in the Lone Star ... list of fastest growing companies in 2014. , The store, which opened July 1 ...
(Date:7/2/2015)... ... ... swing, Americans are flocking to Canada’s many lakes to reel in their fair share of ... it’s easy to understand why. From the Pacific Northwest Coast of British Columbia to the ... huge industry, and Americans make up the vast majority of anglers from outside of Canada. ...
(Date:7/2/2015)... ... July 02, 2015 , ... Global leader and compression innovator, SIGVARIS ... for men. , For style that’s quick on its feet, men will love ... great news for men everywhere because a simple change in socks can dramatically help ...
(Date:7/2/2015)... TX (PRWEB) , ... July ... ... pressure wound therapy (NPWT) - pipeline review 2015” provides comprehensive information on ... of development. Complete report on negative pressure wound therapy (NPWT) with 22 ...
(Date:7/2/2015)... ... July 02, 2015 , ... Breakthrough technologies ... pain treatment. Dr. Lev Kalika, founder of New York Dynamic Neuromuscular Rehabilitation ... on the conservative treatment of back, hip, knee and shoulder pain as well ...
Breaking Medicine News(10 mins):Health News:sweetFrog Expands Texas Footprint with Location in Canton 2Health News:SIGVARIS Kicks Up Its Style for Men with the Launch of MIDTOWN MICROFIBER in a Dark Navy Stripe Pattern 2Health News:SIGVARIS Kicks Up Its Style for Men with the Launch of MIDTOWN MICROFIBER in a Dark Navy Stripe Pattern 3Health News:Negative Pressure Wound Therapy (System, Wound Care, Tissue Cooling NPWT) Pipeline Review 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Negative Pressure Wound Therapy (System, Wound Care, Tissue Cooling NPWT) Pipeline Review 2015 Market Research Report Available at RnRMarketResearch.com 3Health News:Negative Pressure Wound Therapy (System, Wound Care, Tissue Cooling NPWT) Pipeline Review 2015 Market Research Report Available at RnRMarketResearch.com 4Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 2Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 3Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 4
... Calif., March 31 Alexza,Pharmaceuticals, Inc. (Nasdaq: ALXA ... financing facility under which it may sell up to ... Ltd. over a,24-month period. Alexza is not obligated to ... to enter into and consummate other equity and,debt financing ...
... occur , , MONDAY, March 31 (HealthDay News) -- Cerebral ... from red blood cells that have leaked out of ... over age 60 than previously believed, according to a ... higher overall prevalence of cerebral microbleeds compared to other ...
... WILMINGTON, N.C., March 31 PPD, Inc. (Nasdaq:,PPDI) ... as executive,vice president of global clinical development. In ... company,s Phase II-IV operations in,North America; Latin America; ... "Mike Wilkinson brings an exceptional resume with strong ...
... A Saint Louis University cardiologist called upon the U.S. ... strong warning it recently placed on a diagnostic tool, ... life-threatening cardiac events. , In October 2007, the ... agents, which are used to improve the quality of ...
... following was,issued today by the National Press Club:, National ... 2:00 p.m., National Press Club (Broadcast Center), ... will discuss,Quality as a Path to Improving the Cost of ... patient safety and health care products and,services company, R. Kerry ...
... By Will Arnett, Matthew Broderick, Steve Carell, Stephen, ... Kevin James,Conan O,Brien, Rosie O,Donnell, Amy Poehler, Adam Sandler, ... The Insult Comic Dog And Many More To Be ... announced today that,Kelsey Grammer, Ben Stiller, Grammy Award-winning band ...
Cached Medicine News:Health News:Alexza Secures $50 Million Committed Equity Financing Facility With Azimuth Opportunity, Ltd. 2Health News:Alexza Secures $50 Million Committed Equity Financing Facility With Azimuth Opportunity, Ltd. 3Health News:Alexza Secures $50 Million Committed Equity Financing Facility With Azimuth Opportunity, Ltd. 4Health News:Small Brain Lesions More Common Than Thought in Those Over 60 2Health News:PPD Names Mike Wilkinson Executive Vice President of Global Clinical Development 2Health News:PPD Names Mike Wilkinson Executive Vice President of Global Clinical Development 3Health News:New research shows benefits of ultrasound contrast agents outweigh potential risk to heart patients 2Health News:New research shows benefits of ultrasound contrast agents outweigh potential risk to heart patients 3Health News:Kelsey Grammer, Ben Stiller, Maroon 5 and The Roots Added to COMEDY CENTRAL's(R) Live On-air Charity Special 'Night of Too Many Stars: An Overbooked Concert for Autism Education' Hosted by Jon Stewart on Sunday April 13, at 8 p.m. ET 2
(Date:7/2/2015)... July 2, 2015 BGI announced today that ... Kong has been accredited by the American ... the first clinical next-generation-sequencing laboratory to receive the CAP ... highest standard in clinical laboratory practices. Complementary to the exiting ... process, and multiple ISO certifications, the CAP certification enables ...
(Date:7/2/2015)... 2, 2015 Agreement ... to HIV treatments   ViiV Healthcare ... to enable production in China of ... dolutegravir active pharmaceutical ingredient (API), and will allow ViiV Healthcare ... 50mg, marketed under the name Tivicay®) for China ...
(Date:7/1/2015)... , July 1, 2015 ContraVir Pharmaceuticals, Inc. ... the development and commercialization of targeted antiviral therapies, announced ... Inaugural Healthcare Conference taking place in New ... Le Parker Meridien Hotel. James ... of the Company,s business during his live presentation and ...
Breaking Medicine Technology:BGI Receives Accreditation from the College of American Pathologists (CAP) 2ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 2ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 3ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 4ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 5ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 6ContraVir to Present at Cantor Fitzgerald Inaugural Healthcare Conference 2
... 17, 2011 Endo Pharmaceuticals (Nasdaq: ENDP ) ... collaboration related to the development of axomadol. Endo licensed exclusive ... and Canada from Grunenthal in February 2009. ... remains committed to the development and commercialization of pain therapeutics," ...
... 17, 2011 Polymedco is pleased to announce ... Screening in Integrated Health Care Systems" by Theodore ... Reyes, Michael Oehrli, and Cindy Caldwell (Epidemiol Rev ... for Colorectal cancer (CRC) at Kaiser Permanente Northern ...
Cached Medicine Technology:Endo Pharmaceuticals Announces Termination of Collaboration with Grunenthal for the Development of Axomadol 2Polymedco Announces Publication in Epidemiologic Reviews 2
Biotest ELPHA (=Enzyme Linked Probe Hybridization Assay) for class I and class II HLA typing shows convincing advantages for your lab routine....
This ELISA test is used for the detection and semi-quantitation of lgG antibobies to proteinase 3(pr3) in human sera, as an aid to the diagnosis of wegener s granulomatosis....
... for the semi-quantitative determination of specific ... serum. The results of the anti-GBM.assay ... in the diagnosis of diseases associated ... including Goodpastures Syndrome. Levels of these ...
The assay is an immunometric ('sandwich') EIA for the quantitative measurement of LH in human serum or plasma. LH in the sample is bound by 2 monoclonal anti-LH antibodies directed at different epito...
Medicine Products: